Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.
- M. Fray, R. P. Dickinson, J. Huggins, N. Occleston
- Chemistry, Medicine
- Journal of medicinal chemistry
- 4 July 2003
The pathology of chronic dermal ulcers is characterized by excessive proteolytic activity which degrades extracellular matrix (required for cell migration) and growth factors and their receptors. The… Expand
Suppressive Regulatory T Cell Activity Is Potentiated by Glycogen Synthase Kinase 3β Inhibition*
- J. A. Graham, M. Fray, +11 authors A. Alessandrini
- Biology, Medicine
- The Journal of Biological Chemistry
- 20 August 2010
The mechanism by which regulatory T (Treg) cells suppress the immune response is not well defined. A recent study has shown that β-catenin prolongs Treg cell survival. Because β-catenin is regulated… Expand
Matrix Metalloproteinase-3 Differences in Oral and Skin Fibroblasts
- S. McKeown, J. Barnes, P. Hyland, F. Lundy, M. Fray, C. Irwin
- Chemistry, Medicine
- Journal of dental research
- 1 May 2007
While skin wounds heal by scarring, wounds of oral mucosa show privileged healing with minimal scar formation. Our hypothesis was that phenotypic differences between oral and skin fibroblasts… Expand
Implementation of the Manual Handling Directive in the healthcare industry in the European Union for patient handling tasks
- S. Hignett, M. Fray, +7 authors C. Johnsson
- Business
- 1 May 2007
Abstract In 1990 the European Union (EU) introduced a directive to protect workers against the risks involved in handling heavy loads. This paper reports on a benchmarking exercise to (a) investigate… Expand
Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
- M. Fray, G. Bish, P. V. Fish, A. Stobie, Florian Wakenhut, G. Whitlock
- Chemistry, Medicine
- Bioorganic & medicinal chemistry letters
- 15 August 2006
We report the structure-activity relationships of further analogues in a series of piperazine derivatives as dual inhibitors of serotonin and noradrenaline reuptake, that is, with additional… Expand
Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.
- J. Adams, E. C. Anderson, +19 authors S. Macdonald
- Medicine
- ACS medicinal chemistry letters
- 30 September 2014
Antagonism of αvβ6 is emerging as a potential treatment of idiopathic pulmonary fibrosis based on strong target validation. Starting from an αvβ3 antagonist lead and through simple variation in the… Expand
International consensus on manual handling of people in the healthcare sector: Technical report ISO/TR 12296
- S. Hignett, M. Fray, +6 authors M. Jaeger
- Engineering
- 2014
Abstract In 1990 the European Union introduced a directive on manual handling in the health and social care industries. A review of the implementation in 2004 found a wide variation in official… Expand
Dendritic cell maturation occurs through the inhibition of GSK-3β.
- A. Alessandrini, S. de Haseth, +5 authors G. Benichou
- Biology, Medicine
- Cellular immunology
- 2011
Dendritic cell (DC) maturation results in changes in antigen processing and presentation, governing the fate of adaptive immunity. Understanding the intracellular signaling pathways governing DC… Expand
Structure-activity relationships of 1,4-dihydro-(1H,4H)-quinoxaline-2,3-diones as N-methyl-D-aspartate (glycine site) receptor antagonists. 1. Heterocyclic substituted 5-alkyl derivatives.
- M. Fray, D. Bull, C. Carr, E. Gautier, C. Mowbray, A. Stobie
- Chemistry, Medicine
- Journal of medicinal chemistry
- 5 May 2001
A series of 6,7-dichloro-1,4-dihydro-(1H, 4H)-quinoxaline-2,3-diones (1-17) were prepared in which the 5-position substituent was a heterocyclylmethyl or 1-(heterocyclyl)-1-propyl group.… Expand
1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
- K. Cooper, M. Fray, M. J. Parry, K. Richardson, J. Steele
- Chemistry, Medicine
- Journal of medicinal chemistry
- 21 August 1992
A novel class of 2-(4-heterocyclylphenyl)-1,4-dihydropyridines (2-38) possessing antagonist activity against platelet activating factor (PAF) was prepared by the Hantzsch synthesis from a variety of… Expand